Announcement, Our Impact 03.13.23 Share on Twitter Share on Facebook Share on LinkedIn PICI Network Researchers to Present at SITC Spring Scientific Investigators from the Parker Institute for Cancer Immunotherapy (PICI) Network will discuss factors that affect the host and response to immunotherapy beyond the tumor microenvironment, at the Society for Immunotherapy of Cancer (SITC) Spring Scientific, March 15-17 in Denver and online. The conference, titled “Host Immunity in Immunotherapy Responses: From Discoveries to Precision Oncology,” will include discussions of scientific breakthroughs, cutting-edge methodologies and technologies, and clinical studies pertaining to environmental, genetic and patient-specific factors that affect patient health and response to immunotherapy. Session co-chairs and presenters include these PICI Network members: John Wherry, PhD, (Twitter: @EJohnWherry) co-center director of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania and chair of the Department of Systems Pharmacology & Translational Therapeutics at Penn Matthew H. Spitzer, PhD, (Twitter: @SpitzerLab), an associate professor of otolaryngology at the University of California, San Francisco and an affiliate investigator at Gladstone Institutes Avery D. Posey, PhD, (Twitter: @IAmDrDex) an instructor in the Department of Pathology and Laboratory Medicine at Penn Kenneth Hu, PhD, (Twitter: @KenHu77) a postdoctoral scholar and Parker Bridge Fellow (in partnership with the V Foundation for Cancer Research) at University of California San Francisco, also will present. Additional details are below. All times are Mountain Daylight Time. Please note that all events listed are subject to change. For the most current information, visit the conference program. Wednesday, March 15 Session: Workshop: Integrating Spatial-Omics in IO/Single Cell Analysis Presenter: Kenneth Hu, PhD Presentation: Image Analysis of Immune Contexture Time: 3:40 p.m. Thursday, March 16 Session: Session V: Immune-Related Toxicity and COVID Co-Chair and Presenter: E. John Wherry, PhD Time: 9:35-10:50 a.m. Presentation: Use of ‘Analytical Vaccination’ to Predict Immune Related Adverse Events to Checkpoint Blockade Time: 10:15 a.m. Session: Session VI: Novel Insights into Adoptive Cell Therapy Co-Chair and Presenter: Avery D. Posey, PhD Time: 11:05 a.m.-12:20 p.m. Presentation: Tumor Mechanisms of Resistance to CAR T Cells Time: 11:07 a.m. Friday, March 17 Session: Session VIII: Insights from Non-Tumor Sites in IO Response Co-Chair and Presenter: Matthew H. Spitzer, PhD Time: 9:35-10:50 a.m. Presentation: CD8 T Cell Responses to Cancer Immunotherapy in Human Lymph Nodes Time: 9:35 a.m. Related Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research Announcement PICI Network Investigators Propel Immunotherapy Progress at SITC 2024 Announcement, Press Release PICI’s 2024 Fall Scientific Retreat Ignites Collaboration to Accelerate Cancer Immunotherapy
Announcement, Press Release Parker Institute Awards $525,000 to Advance Diverse Talent in Cancer Research
Announcement, Press Release PICI’s 2024 Fall Scientific Retreat Ignites Collaboration to Accelerate Cancer Immunotherapy